Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Optimizing the HS Clinic Visit: Overcoming Barriers to Care for the Busy Clinician
Description
In this webinar, Leandra Barnes discusses strategies to optimize clinic visits for patients with Hidradenitis Suppurativa (HS), a chronic inflammatory skin condition. With a prevalence of 1% in the U.S. and an average diagnostic delay of 7 to 10 years, HS disproportionately affects women and minorities, leading to significant barriers to care such as inadequate treatment options, cost, and stigma. Barnes emphasizes the importance of understanding these barriers from both the patient and clinician perspectives. Key strategies to improve care include preparing for visits by reviewing patient information in advance, educating support staff, and creating efficient clinic environments with necessary supplies. During consultations, it is crucial to build trust through empathy, clear communication, and addressing each patient's unique concerns. The discussion also covers the significance of educating patients on HS myths, treatment options, and the importance of follow-up care. Providing after-visit handouts and developing triage systems can enhance patient management and minimize emergency visits. Overall, improving HS care requires a collaborative, informed approach to address the multifaceted challenges faced by both patients and healthcare providers.
View moreConclusions
- Hidradenitis Suppurativa (HS) is underrecognized and faces significant diagnostic delays and barriers to care.
- Patients with HS experience a profound quality of life impact due to limited treatment options and disparities in care access.
- Healthcare professionals often lack knowledge about HS, contributing to negative patient experiences and stigma.
- Optimizing the HS clinic visit involves preparation, empathy, and effective communication to address patient needs.
- Implementing systematic approaches like pre-visit intake forms and clinic workflows can enhance patient-centered care for HS.
- Early intervention and personalized treatment plans are crucial to prevent disease progression in HS patients.
- Providing ongoing resources and support groups post-visit can empower HS patients in managing their condition.
- Alikhan S., et al. JAAD. 2009.
- Buimer M., et al. Br J Surg. 2009.
- Garg A., et al. JAAD. 2021.
- Nguyen T., et al. J Eur Acad Dermatol Venereol. 2021.
- Saunte D. B. I., et al. BJD. 2015.
- Bouazzi A., et al. BJD. 2021.
- Kirby B., et al. BJD. 2020.
- Montero-Vilchez T., et al. Int J Environ Res Public Health. 2021.
- Alavi A., et al. AJCD. 2015.
- Leis T. and Findlay G. JID. 2014.
- Tamasi R. BJD. 2018.
- Garg A., et al. JAAD. 2020.
- Shih P. I., et al. Int J Womens Dermatol. 2022.
- Barnes L. A., et al. JAMA Derm. 2023.
- Shih P. I., et al. JAAD. 2023.
- Flood K., et al. JAAD. 2021.
- Zouboulis C. C., et al. Dermatology. 2015.
- Sabat R., et al. Nature Reviews Disease Primers. 2020.
- Kirby B., et al. Br J Dermatol. 2020.
- Martorell A., et al. Actas Derm. 2016.